Scott E. McNeil

13.5k total citations · 6 hit papers
63 papers, 10.1k citations indexed

About

Scott E. McNeil is a scholar working on Biomaterials, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Scott E. McNeil has authored 63 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biomaterials, 23 papers in Materials Chemistry and 17 papers in Molecular Biology. Recurrent topics in Scott E. McNeil's work include Nanoparticle-Based Drug Delivery (24 papers), Nanoparticles: synthesis and applications (21 papers) and RNA Interference and Gene Delivery (8 papers). Scott E. McNeil is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), Nanoparticles: synthesis and applications (21 papers) and RNA Interference and Gene Delivery (8 papers). Scott E. McNeil collaborates with scholars based in United States, Switzerland and Netherlands. Scott E. McNeil's co-authors include Marina A. Dobrovolskaia, Jennifer B. Hall, Parag Aggarwal, Jeffrey D. Clogston, Anil K. Patri, Christopher B. McLeland, Stęphan T. Stern, Barry W. Neun, Rachael M. Crist and Jiwen Zheng and has published in prestigious journals such as Nano Letters, Nature Nanotechnology and Advanced Drug Delivery Reviews.

In The Last Decade

Scott E. McNeil

61 papers receiving 9.9k citations

Hit Papers

Nanoparticle interaction with plasma proteins as it relat... 2007 2026 2013 2019 2009 2007 2008 2008 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
    2009 1.4k citations Jennifer B. Hall, Marina A. Dobrovolskaia et al. profile →
  2. Immunological properties of engineered nanomaterials
    2007 1.4k citations Marina A. Dobrovolskaia, Scott E. McNeil Nature Nanotechnology profile →
  3. Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
    2008 800 citations Marina A. Dobrovolskaia, Jennifer B. Hall et al. profile →
  4. Method for Analysis of Nanoparticle Hemolytic Properties in Vitro
    2008 583 citations Marina A. Dobrovolskaia, Jeffrey D. Clogston et al. profile →
  5. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
    2008 554 citations Marina A. Dobrovolskaia, Anil K. Patri et al. profile →
  6. Zeta potential: a case study of cationic, anionic, and neutral liposomes
    2017 346 citations Rachael M. Crist, Jeffrey D. Clogston et al. Analytical and Bioanalytical Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott E. McNeil United States 38 4.4k 3.4k 3.3k 2.9k 910 63 10.1k
Hamidreza Ghandehari United States 62 6.0k 1.4× 3.7k 1.1× 2.4k 0.7× 5.1k 1.7× 702 0.8× 210 12.8k
Anna Salvati Netherlands 48 5.6k 1.3× 4.5k 1.3× 5.0k 1.5× 4.4k 1.5× 788 0.9× 119 13.8k
Marina A. Dobrovolskaia United States 50 5.0k 1.1× 4.1k 1.2× 3.6k 1.1× 5.0k 1.7× 2.4k 2.6× 170 13.5k
Aaron C. Anselmo United States 41 4.0k 0.9× 4.4k 1.3× 1.9k 0.6× 4.1k 1.4× 1.1k 1.2× 69 11.5k
Yan Wu China 50 3.1k 0.7× 3.9k 1.1× 2.0k 0.6× 2.9k 1.0× 512 0.6× 208 9.0k
Frank Gu Canada 48 4.7k 1.1× 4.4k 1.3× 2.3k 0.7× 3.7k 1.3× 356 0.4× 145 11.7k
Elvin Blanco United States 33 4.4k 1.0× 4.0k 1.2× 1.5k 0.5× 3.4k 1.1× 661 0.7× 61 8.9k
A. Christy Hunter United Kingdom 36 4.3k 1.0× 2.9k 0.8× 1.5k 0.5× 4.3k 1.5× 952 1.0× 90 9.6k
Haifa Shen United States 46 4.4k 1.0× 4.4k 1.3× 1.7k 0.5× 5.6k 1.9× 1.4k 1.5× 125 11.6k
Siling Wang China 62 5.1k 1.2× 5.8k 1.7× 4.5k 1.4× 3.2k 1.1× 752 0.8× 235 12.8k

Countries citing papers authored by Scott E. McNeil

Since Specialization
Citations

This map shows the geographic impact of Scott E. McNeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. McNeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. McNeil more than expected).

Fields of papers citing papers by Scott E. McNeil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. McNeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. McNeil. The network helps show where Scott E. McNeil may publish in the future.

Co-authorship network of co-authors of Scott E. McNeil

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. McNeil. A scholar is included among the top collaborators of Scott E. McNeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. McNeil. Scott E. McNeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dinamarca, Margarita C., et al.. (2025). Mannose-6-phosphate-PEG-lipid conjugates improve liposomal uptake. European Journal of Pharmaceutics and Biopharmaceutics. 209. 114665–114665.
2.
McNeil, Scott E., et al.. (2023). Active ingredient vs excipient debate for nanomedicines. Nature Nanotechnology. 18(7). 692–695. 30 indexed citations
3.
Vlieger, Jon S. B. de, Daan J.A. Crommelin, Katherine M. Tyner, et al.. (2019). Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”. The AAPS Journal. 21(4). 56–56. 40 indexed citations
4.
Crist, Rachael M., et al.. (2018). Ion quantification in liposomal drug products using high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 165. 41–46. 8 indexed citations
5.
Crist, Rachael M., et al.. (2017). Zeta potential: a case study of cationic, anionic, and neutral liposomes. Analytical and Bioanalytical Chemistry. 409(24). 5779–5787. 346 indexed citations breakdown →
6.
Dobrovolskaia, Marina A. & Scott E. McNeil. (2016). Handbook of Immunological Properties of Engineered Nanomaterials: Volume 1: Key Considerations for Nanoparticle Characterization Prior to Immunotoxicity Studies. WORLD SCIENTIFIC eBooks. 2 indexed citations
7.
Crommelin, Daan J.A., Vinod P. Shah, Imre Klebovich, et al.. (2015). The similarity question for biologicals and non-biological complex drugs. European Journal of Pharmaceutical Sciences. 76. 10–17. 54 indexed citations
8.
Dobrovolskaia, Marina A. & Scott E. McNeil. (2015). Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert Opinion on Biological Therapy. 15(7). 1023–1048. 38 indexed citations
9.
Dobrovolskaia, Marina A. & Scott E. McNeil. (2015). Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert Opinion on Drug Delivery. 12(7). 1163–1175. 36 indexed citations
10.
McNeil, Scott E., et al.. (2015). Stable isotope method to measure drug release from nanomedicines. Journal of Controlled Release. 220(Pt A). 169–174. 36 indexed citations
11.
Hansen, Matthew, et al.. (2015). Analyzing the influence of PEG molecular weight on the separation of PEGylated gold nanoparticles by asymmetric-flow field-flow fractionation. Analytical and Bioanalytical Chemistry. 407(29). 8661–8672. 16 indexed citations
12.
Adiseshaiah, Pavan P., Anthony Dellinger, Marina A. Dobrovolskaia, et al.. (2013). A Novel Gadolinium-Based Trimetasphere Metallofullerene for Application as a Magnetic Resonance Imaging Contrast Agent. Investigative Radiology. 48(11). 745–754. 15 indexed citations
13.
Stern, Stęphan T., Peng Zou, Sherwin Xie, et al.. (2013). Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion. Journal of Controlled Release. 172(2). 558–567. 8 indexed citations
14.
Dobrovolskaia, Marina A. & Scott E. McNeil. (2013). Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. Journal of Controlled Release. 172(2). 456–466. 226 indexed citations
15.
Peifley, Kimberly A., Stephen Lockett, Barry W. Neun, et al.. (2010). Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicology and Applied Pharmacology. 248(3). 249–258. 144 indexed citations
16.
Stern, Stęphan T., Jennifer B. Hall, Lee L. Yu, et al.. (2010). Translational considerations for cancer nanomedicine. Journal of Controlled Release. 146(2). 164–174. 73 indexed citations
17.
Adiseshaiah, Pavan P., Jennifer B. Hall, & Scott E. McNeil. (2009). Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2(1). 99–112. 180 indexed citations
18.
Dobrovolskaia, Marina A. & Scott E. McNeil. (2007). Immunological properties of engineered nanomaterials. Nature Nanotechnology. 2(8). 469–478. 1368 indexed citations breakdown →
19.
Chan, King C., Anil K. Patri, Timothy D. Veenstra, Scott E. McNeil, & Haleem J. Issaq. (2007). Analysis of fullerene‐based nanomaterial in serum matrix by CE. Electrophoresis. 28(10). 1518–1524. 18 indexed citations
20.
Stickle, Douglas F. & Scott E. McNeil. (1999). Evaluation of use of singleton measurements of C-peptide by RIA. Clinica Chimica Acta. 283(1-2). 195–200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamidreza Ghandehari Breakdown of academic impact, for papers by Anna Salvati Breakdown of academic impact, for papers by Marina A. Dobrovolskaia Breakdown of academic impact, for papers by Aaron C. Anselmo Breakdown of academic impact, for papers by Yan Wu Breakdown of academic impact, for papers by Frank Gu Breakdown of academic impact, for papers by Elvin Blanco Breakdown of academic impact, for papers by A. Christy Hunter Breakdown of academic impact, for papers by Haifa Shen Breakdown of academic impact, for papers by Siling Wang
Rankless by CCL
2026